Peter T. Slover's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 110,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Contineum Therapeutics Inc... | Peter T. Slover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
Contineum Therapeutics Inc... | Peter T. Slover | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |